Research Summary
Dr. Kornberg conducts basic and translational research aimed at better understanding the pathogenesis of multiple sclerosis, particularly the processes that drive progressive disability such a neurodegeneration and remyelination failure.
Lab
Lab Website: Kornberg Lab
Technology Expertise Keywords
multiple sclerosis; progressive multiple sclerosis; immunometabolism; neuroinflammation; nitric oxide
Clinical Trial Keywords
multiple sclerosis, progressive multiple sclerosis, immunometabolism, neuroinflammation, nitric oxide
Selected Publications
View all on PubMed
Kornberg MD and Calabresi PA. (in press) "Emerging Therapies for Multiple Sclerosis." In Robert J Fox, Alexander D Rai-Grant, Francois Bethoux (Editors), Multiple Sclerosis and Related Disorders: Clinical Guide to Diagnosis, Medical management, and Rehabilitation, 2nd edition. New York, NY:Demos Medical Publishing
Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, Calabresi PA, and Snyder SH. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science (2018) 360:449-453; published online 29 March 2018 (10.1126/science.aan4665), PMID: 29599194
Kornberg MD, Smith MD, Shirazi HA, Calabresi PA, Snyder SH, and Kim PM. Bryostatin-1 alleviates experimental multiple sclerosis. Proc Natl Acad Sci U.S.A. (2018) 115:2186-2191.PMID: 29440425
Yeshokumar AK, Saylor D, Kornberg MD, and Mowry EM. Evidence for the importance of vitamin D status in neurologic conditions. Curr Treat Options Neurol (2015) 17:51. PMID: 26538263
Kornberg MD, Ratchford JN, Subramaniam RM, and Probasco JC. Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves. BMJ Case Rep (2015) Apr 9.PMID 25858943